FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
, , Dilip Davda, , , and have given "Apply" recommendation to Thyrocare Technologies IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 7 | 0 | 0 | 0 | 0 |
% | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Apply | ||
Apply | ||
Dilip Davda | Apply | |
Apply | ||
Apply | ||
Apply | ||
Apply |
The Captial Market (CapitalMarket.com) rating for Thyrocare Technologies IPO is 44. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 44 | Avoid, however active risk seekers can try |
[Dilip Davda]
Considering the brand image and the operational methods, the company is poised for bright prospects ahead. Investment in this IPO will bring reasonable rewards in coming years. Investment may be considered for short to long term.
Read detail review...Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|